Home > Press > H&H Group Invests Additional $2,500,000 in Molecular Imprints
Abstract:
Total investment in Molecular Imprints $4.5 million
Harris & Harris Group, Inc.®, announced today that it invested an
additional $2,500,000 in privately held Molecular Imprints, Inc., of
Austin, TX, bringing its total investment in Molecular Imprints to
$4,500,000. The investment was as part of a Series C financing that
raised $17 million in the first closing of a planned $25 million
Series C financing. Molecular Imprints provides enabling
lithography systems for manufacturing applications in: nano devices,
LEDs for solid state lighting, magnetic data storage for micro disk
drives and others. Other investors participating in this financing
include Dai Nippon Printing Company (DNP), Alloy Ventures, Motorola
Ventures, Draper Fisher Jurvetson, Hakuto Co., Ltd., Asset
Management and others. Molecular Imprints will use the money to
expand its Imprio® product line.
Harris & Harris Group is a publicly traded venture capital company
that now makes initial investments exclusively in tiny technology,
including nanotechnology, microsystems and microelectromechanical
systems (MEMS). The Company's last 24 initial private equity
investments have been in tiny-technology enabled companies. The
Company has 20,756,345 shares of common stock outstanding.
Detailed information about Harris & Harris Group and its holdings
can be found on its website at www.TinyTechVC.com.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
Investments/IPO's/Splits
Daikin Industries becomes OCSiAl shareholder July 27th, 2021
INBRAIN Neuroelectronics raises over €14M to develop smart graphene-based neural implants for personalised therapies in brain disorders March 26th, 2021
180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||